Brown v. Lane County

CourtDistrict Court, D. Oregon
DecidedMarch 12, 2024
Docket6:21-cv-01866
StatusUnknown

This text of Brown v. Lane County (Brown v. Lane County) is published on Counsel Stack Legal Research, covering District Court, D. Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brown v. Lane County, (D. Or. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF OREGON

EUGENE DIVISION

ANTHONY BROWN, Case No. 6:21-cv-01866-AA OPINION AND ORDER Plaintiff,

vs.

LANE COUNTY; DR. ALFREDO VELEZ; NATHAN L. GENT; WELLPATH, LLC; JOHN/JANE DOES 1-5,

Defendants.

AIKEN, District Judge: Plaintiff Anthony Brown proceeds in forma pauperis (“IFP”) in this civil rights action against defendant Dr. Alfredo Velez. Before the Court is defendant’s motion for summary Judgment (“Mot.”), ECF No. 40, and plaintiff’s motion to amend or correct his answers to defendant’s requests for admissions (“RFA Mot.”), ECF No. 42. For the reasons explained below, defendant’s motion for summary judgment, ECF No. 40, is GRANTED. Plaintiff’s RFA motion, ECF No. 42, is DENIED. BACKGROUND Plaintiff was incarcerated at Lane County Adult Correctional Facility for an Assault 4, strangulation charge in October 2019. SAC ¶ 9. There, he received mental health treatment from providers including defendant Dr. Velez, a Wellpath employee. Plaintiff’s medical records describe a history of anxiety, depression, attention deficit hyperactivity, and panic disorders, including an occasion where a “panic attack . . .

turned into a seizure.” Taylor Decl. Ex. 1 at 0044-45; 48-49.1 Plaintiff stopped taking his prescribed mental health medications and told his health providers that he had been smoking meth daily. Id. In December 2019, plaintiff expressed interest in returning to medical management of his mental health. Id. at 0024. I. Plaintiff Begins Treatment On December 24, 2019, defendant met with plaintiff. Id. at 0023. The record shows a notation that plaintiff was “guarded in his presentation” and “afraid to

divulge many details of his recent [history]” due to “shame and guilt over his meth use.” Id. at 0022. Plaintiff told defendant that he had previously been diagnosed with PTSD and bipolar disorder and was currently experiencing “daily anxiety and insomnia” along with hearing “voices at night.” Id. He could not recall which prior meds he had or had not taken or found effective. Id. Defendant prescribed Depakote2 and Desyrel/Trazodone.3 Taylor Decl., Ex. 1 at 0022.

1 Medical records are included as exhibits in the Declaration of Ross Taylor. The Court will cite to the pagination marked in the bottom right-hand corner, after the abbreviation “ABRO.”

2 Depakote (divalproex sodium) has been approved by the U.S. Food and Drug Administration for use to treat bipolar disorder. https://www.accessdata.fda.gov/drugsatfda docs/labe1/2011/018723s0371b1.pdf

3 Desyrel (trazodone) is a selective serotonin reuptake inhibitor (SSRI) approved for treatment of depressive disorder. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf Defendant discussed with plaintiff the “risks and benefits, effects and [side effects]” of the medications. Id. at 0023. Plaintiff memorialized his agreement that: he had been informed that there was no guarantee of benefit; that the side effects had been

discussed with him; and that he could choose to withdraw consent at any time. Id. at 0051. Evidence in the record is that plaintiff received the first dose of both the medications he was prescribed that very same night of December 24, 2019. Id. at 0002. The medications were provided as ordered over the following days. On December 29, 2019, plaintiff asked to “see someone” about his “treatment program” and release plan, expressing concern that the Trazadone was “not working very well”

and that he was experiencing side effects. Id. at 0057. In response to plaintiff’s request, defendant held an appointment with him on December 31, 2019. Id. at 0032. Although at the first visit, plaintiff could not recall his prior medications, he now related that he used to take Seroquel to good effect. Id. Plaintiff also requested to try an SSRI for his anxiety. Id. Based on plaintiff’s requests and representations, defendant discontinued the Trazodone and started him on

Doxepin4 and Escitalopram.5 Defendant also increased plaintiff’s Depakote dose because plaintiff described it as not “having enough effect.” Taylor Decl., Ex 1 at 0032. II. Plaintiff’s Episode with Guards, Physicians

4 Doxepin is indicated for treatment of depression and/or anxiety. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/070791s027lbl.pdf 5 Escitalopram (Lexapro) is a selective serotonin reuptake inhibitor (SSRI) indicated for treatment of depression and/or anxiety. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021323s047lbl.pdf On January 3, 2020, jail medical staff responded to a call about plaintiff demonstrating odd behaviors. Id. at 0018-19. Plaintiff was found lying on his mattress and generally would not verbally respond to any staff. Id. Although none of

his vital signs were abnormal, his providers and jail personnel determined he should be taken to the medical unit for further evaluation. Id. On his way to the medical evaluation, plaintiff stood and walked, at times resisting deputies. Id. At the medical unit, plaintiff told deputies that he was not suicidal, but would not respond to any other questions. Id. A plan was developed to regularly check on plaintiff, with a factor in this decision being that plaintiff had been recently caught hiding and not taking his Depakote. Id. at 0018-19.

III. Plaintiff’s Medication Refusals vs. Requests to Increase Medication The next day, a mental health provider checked on plaintiff in the medical unit. Id. at 0031. Plaintiff stated that he was not sure why he had “passed out” the day prior but guessed that it was “potentially an allergic reaction.” Id. Plaintiff reported that since January 3, 2020, he had refused his doses of Doxepin and Escitalopram “because he did not like” how they made him feel. Id.

Although he expressed the Depakote was “helping” with his depression, he had been refusing that medication as well. Id. (reporting a benefit from the Escitalopram); Id. at 0002 (showing plaintiff’s refusals). Plaintiff accepted one more dose of Depakote on January 6, 2020, but after later refusals, the jail the Depakote. Id. at 0002, 11. On January 8, 2020, plaintiff submitted two non-emergent health service requests, one asking for an increase in his medications and the other claiming that he had been given too much Depakote. Id. at 0059-60. However, the medical record shows that plaintiff had been refusing Depakote, and that the jail was no longer offering it to plaintiff. Id. at 0002, 11.

Days later, on January 12, plaintiff again requested an increase of his medications, which would be one of many such requests he would make over the remainder of his incarceration. Id. at 0061 (January 12, 2020, request); see also, e.g., Id. at 0071, 73-74. Plaintiff repeated his claim that the jail had provided him too much Depakote on January 13, 2020, even though that medication was no longer being offered. Id. at 0029. IV. Subsequent Care and Diagnosis

On January 15, 2020, plaintiff was seen by psychologist, Cherul Gifford. Id. at 28-39. After evaluating plaintiff, she recorded an assessment of “epileptic episodes v. malingering.” Id. at 0028-29. Plaintiff was next evaluated by a medical Nurse Practitioner who found plaintiff to be a “very poor historian” and, after evaluation, found plaintiff to be in good health outside of a headache. Id. On January 21, 2020, defendant Dr. Velez followed up in response to plaintiff’s claimed “episodes.” Id. at

0040-41. Plaintiff was alert and oriented and his cognition appeared intact. Id. Through consultation, plaintiff agreed to try a new medication as a substitute for the Depakote. Id. Plaintiff remained incarcerated into May of 2020, receiving ongoing medical and mental health treatment, including encounters with defendant Dr. Velez.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Joshi v. Providence Health System of Oregon Corp.
149 P.3d 1164 (Oregon Supreme Court, 2006)
Getchell v. Mansfield
489 P.2d 953 (Oregon Supreme Court, 1971)
Henderson v. Union Pacific Railroad
219 P.2d 170 (Oregon Supreme Court, 1950)
Sims v. Dixon
355 P.2d 478 (Oregon Supreme Court, 1960)
Cleland v. Wilcox
543 P.2d 1032 (Oregon Supreme Court, 1975)
Stevens v. Bispham
851 P.2d 556 (Oregon Supreme Court, 1993)
Joshi v. Providence Health System of Oregon Corp.
108 P.3d 1195 (Court of Appeals of Oregon, 2005)
Horn v. National Hospital Association
131 P.2d 455 (Oregon Supreme Court, 1942)
Philibert v. Kluser
385 P.3d 1038 (Oregon Supreme Court, 2016)
William Stephens v. Union Pacific Railroad Company
935 F.3d 852 (Ninth Circuit, 2019)
Cabrera v. Cordis Corp.
134 F.3d 1418 (Ninth Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Brown v. Lane County, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brown-v-lane-county-ord-2024.